Anyone supporting a BO of $10 PPS please explain how you value the company. That would equal a market cap of approximately $ 1B at this point. At a P/E ratio of approximately 10 that would imply $ 100,000,000 a year, which would be a hefty discount of potential earnings. A discount one would only get if the product's MOA would be pure speculation mixed with hope.
Are you further indicating that we cannot get an approval even if we partner up? Or that raising money, yes by further dilution, and by hiring a *real* CRO agreeing on full transparency concerning communication with the FDA as well as concentrating on one or two indications is futile?
All the above would imply indirectly agreeing with the manipulators' agenda.